Key result
Propofol, etomidate, and thiopental show no difference in cardiovascular safety or efficacy during electroconvulsive therapy.
Why the study?
Do propofol, etomidate, and thiopental differ in their effects on cardiovascular parameters, seizure variables, and cognitive functions in male patients undergoing electroconvulsive therapy?
Population
Male patients hospitalized at the Seventh Psychiatry Clinics of the Bakırköy Teaching Hospital for…
Comparison
Propofol, etomidate, or thiopental used in… vs Compared against each other
Design
Cohort
Follow-up
Before and after a course of ECT
Authors
Loading...
Supports flexibility in anesthetic selection for ECT; leaves open confirmation by randomized trials.
Cohort
No
Do propofol, etomidate, and thiopental differ in their effects on cardiovascular parameters, seizure variables, and cognitive functions in male patients undergoing electroconvulsive therapy?
Propofol, etomidate, and thiopental demonstrate similar safety and efficacy profiles when used for anesthesia during electroconvulsive therapy.
Canbek et al. (2014) conducted a cohort in Electroconvulsive therapy (ECT). Propofol, etomidate, and thiopental vs. Compared against each other was evaluated on Effects on cardiovascular system parameters, seizure variables, recovery, cognitive functions, and response to treatment. Propofol, etomidate, and thiopental demonstrated similar safety and efficacy profiles, with no significant differences in cardiovascular, seizure, or cognitive variables during electroconvulsive therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: